| Literature DB >> 29463285 |
Ákos Tényi1,2, Isaac Cano3,4, Francesco Marabita5,6, Narsis Kiani5,6, Susana G Kalko3,4,7, Esther Barreiro4,8, Pedro de Atauri9, Marta Cascante9, David Gomez-Cabrero5,6,10, Josep Roca11,12.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) patients often show skeletal muscle dysfunction that has a prominent negative impact on prognosis. The study aims to further explore underlying mechanisms of skeletal muscle dysfunction as a characteristic systemic effect of COPD, potentially modifiable with preventive interventions (i.e. muscle training). The research analyzes network module associated pathways and evaluates the findings using independent measurements.Entities:
Keywords: Chronic obstructive pulmonary disease; Exercise training; Gene modules; Muscular weakness; Systems medicine
Mesh:
Year: 2018 PMID: 29463285 PMCID: PMC5819708 DOI: 10.1186/s12967-018-1405-y
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
Fig. 1Schematic diagram of the workflow of the study. (a) Study design of the used datasets. COPD patients (n = 15) and healthy controls (n = 12) were studied before (BT) and after (AT) an 8-week endurance training program. Measurements of skeletal gene expression [15] were used for network modules identification. Differential conditions of COPD disease effects (COPD-DE) and training-induced effects in COPD (COPD-TE) and in healthy muscles (Healthy-TE) were analyzed in the study. (b) Network modules were identified for each differential condition with the HotNet2 algorithm [22], using the gene’s false discovery rate (FDR) adjusted differential expression P values and selected protein–protein interaction (PPI) networks [17, 23] as explained in details in Additional file 1: Section 1. Thereafter (c), each module was functionally characterized using gene ontology (GO) term enrichment analysis. (d) Correlation of network modules with independent multilevel measurements was analyzed for evaluation purposes. Specifically, independent measurements were sampled both pre- and post-training and consisted of physiological parameters measured with a constant-work rate exercise at 75% of pre-training maximum peak exercise, inflammatory and redox biomarkers measured in plasma and in skeletal muscle [20], as well as plasma metabolomics measured at rest and after exercise [19]
Characteristics of the study groups
| Healthy | COPD | |
|---|---|---|
| Sex (M/F) | 10/2 | 15/0 |
| Age, years | 65 ± 9 | 69 ± 7 |
| FFMI, kg/m2 | 21 ± 2 | 19 ± 3 |
| FEV1, L (mean % pred) | 3.46 ± 0.69 (107) | 1.34 ± 0.37 (46)* |
| FEV1/FVC | 0.75 ± 0.04 | 0.43 ± 0.08* |
| VO2 peak, L/min (mean VO2 peak/kg) | 1.70 ± 0.5 (22) | 0.91 ± 0.3 (14)* |
| [La]a peak, mEq/L | 10.60 ± 2.7 | 6.8 ± 2.3* |
| VO2 peak training diff (post–pre), L/min | 0.25 ± 0.11† | 0.14 ± 0.18† |
| [La]a training diff (post–pre), mEq/L | − 4.60 ± 0.6† | − 1.5 ± 2† |
Results are expressed as mean ± SD
In the post-training study, lactate measurements during constant-work rate exercise were done at the same workload and duration than the pre-training exercise protocol
FFMI fat free mass index, FEV forced expiratory volume in the first second, FEV1/FVC FEV1 to forced vital capacity ratio, VO peak peak oxygen uptake difference post minus pre-training, [La]a arterial lactate concentration difference
Unpaired t test was used to compare controls and COPD, * P < 0.05. Paired t test was used to compare post-training and baseline time points in both healthy controls and COPD patients, †P < 0.05. Low FFMI was defined as < 17.05 kg/m2 for men [21]. It is of note that three COPD patients were discarded from the analysis because they did not pass the Agilent analysis
Summary of experimental data obtained from the same study groups
| Measurements | COPD versus health |
|---|---|
| Plasma metabolomics [ | The two groups showed differences in metabolomic profiles at rest (P < 0.05). Levels of valine, alanine and isoleucine were associated with FFMI (P < 0.01 each) |
| Plasma metabolomics training diff [ | In Healthy, training generated marked changes in amino acids, creatine, succinate, pyruvate, glucose and lactate (P < 0.05 each). But, COPD patients only showed lactate decrease (P < 0.05) |
| Inflammatory cytokines [ | COPD patients showed high levels of circulating cytokines (P < 0.05), not seen in healthy |
| Inflammatory cytokines training diff [ | No training-induced changes were observed in circulating cytokines levels |
| Redox status [ | COPD patients showed blood and muscle oxidative stress at baseline. Muscle and blood protein carbonylation levels were correlated (P < 0.05) |
| Redox status training diff [ | In COPD patients, protein nitration levels decreased after training |
Summary description of the results of previous experimental measurements on plasma metabolomics [19], as well as on both muscle and blood inflammatory cytokines and redox status [20], carried out at rest before training and after endurance training. The term training diff refers to training-induced adaptive changes. For comprehensive list of measured variables see Additional file 2: Tables S2, S7 for the differentials
Fig. 2Disease effects (COPD-DE) network modules. a The four network modules associated to COPD disease effects and their composing genes. Genes are colored according to their differential regulation, namely: up regulation—red nodes; and down regulation—blue nodes. Significantly differentially expressed genes are indicated by * (FDR ≤ 0.05) (for detailed information see Additional file 2: Table S6). b The significant correlations of independent measurements with any of the network modules’ first three principal components. Blue squares depict exercise related independent variables [19]; red squares show cytokines measured in blood [20]; yellow squares correspond to amino acids measured in serum [19]; and, green squares represents redox biomarkers [20]
Fig. 3Relationships between genes from COPD specific modules (disease effects) and previous experimental data. a The relationships between S100A1, from the Ca2+ dependent binding module, and VO2max. The two groups, healthy subjects (blue circles) and COPD patients (low and normal FFMI, empty and filled squares, respectively) fell on the same regression line (R = 0.52, P = 0.006, FDR = 0.026). b The relationships between SMURF1 from the TGF-β signaling module and skeletal muscle nitrosative stress. A statistical significant correlation was seen in the COPD group, both normal and low FFMI (R = − 0.67, P = 0.018 and FDR = 0.07), but not in healthy subjects (R = − 0.2, P = 0.55)
Fig. 4Training effects (TE) network modules. a Active network modules identified in case of COPD-TE, Healthy-TE and in both (shared). Genes are colored according to their differential regulation in COPD-TE (inner color of the nodes) and in Healthy-TE (border color of the nodes): up regulation with training (red circles), down regulation with training (blue circles). Modules are named after significantly enriched GO terms. Training differential expression significance is signed by * for COPD-TE, and § for Healthy-TE (FDR < 0.05) (for detailed information see Additional file 2: Table S6). b The significant correlations of the independent measurements with any of the significantly-changed training modules’ first three principal components in COPD, depicted as purple dashed lines, and in healthy subjects, depicted as blue dotted-dashed lines. Blue squares depict exercise related independent variables; red squares show cytokines measured in blood; and yellow squares correspond to amino acids measured in serum
Fig. 5Relationships between genes from Healthy-TE specific modules and previous experimental plasma metabolomics data. The figure depicts the relationships between training-induced changes in both SF3A3, from the Amino acid biosynthesis module, and glutamine. A strong correlation was seen in healthy subjects (blue circles) (R = 0.70, P = 0.001), but not in COPD patients (low and normal FFMI, empty and filled red squares, respectively) (R = − 0.14, P = 0.518)